ISSN: 1369-0663

Journal Home

Journal Guideline

EBR - European Biopharmaceutical Review Q4 Unclaimed

Samedan Ltd United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

EBR - European Biopharmaceutical Review is a journal indexed in SJR in Pharmaceutical Science with an H index of 6. It has an SJR impact factor of 0,102 and it has a best quartile of Q4. It is published in English. It has an SJR impact factor of 0,102.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Pharmaceutical Science (Q4)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

0,102

SJR Impact factor

6

H Index

0

Total Docs (Last Year)

21

Total Docs (3 years)

0

Total Refs

1

Total Cites (3 years)

19

Citable Docs (3 years)

0

Cites/Doc (2 years)

0.0

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Thai Journal of Pharmaceutical Sciences Q4
Chinese Pharmaceutical Journal Q4
Revista de Ciencias Farmaceuticas Basica e Aplicada Q4
Korean Journal of Pharmacognosy Q4
Pharmaceutical Technology Q4

Compare this journals

EBR - European Biopharmaceutical Review Q4 Unclaimed

- €

NPD

- €

Metrics

0,102

6

0

21

0

1

19

0

0.0

Comments

Other journals with similar parameters

Aims and Scope

FAQS

What is the impact factor of EBR - European Biopharmaceutical Review?